福安药业：公司将持续做好投资者关系管理工作

Core Viewpoint - The company emphasizes its commitment to investor relations management and plans to actively reward investors through cash dividends while conducting market value management within legal and regulatory frameworks [1] Group 1 - The company announced on September 26 that it will continue to enhance its investor relations management efforts [1] - The company intends to actively return value to investors through cash dividends [1] - The company will conduct market value management in a legal and compliant manner [1]